Catheter Precision Showcases Its Innovative 3D Mapping System

Catheter Precision, Inc. (the "Company") (NYSE:VTAK) announced that its innovative 3D Mapping system will be highlighted at several electrophysiology conferences this fall.

Most recently, VIVO was highlighted at the 19th Congresso Nazionale Associazione Italiana di Aritmologia e Cardiostimolazione in Bologna, Italy from September 21-22. Interim CEO David Jenkins remarked, "Our attendance not only highlighted our state-of-the-art technology but also cemented collaborations for evaluations at prominent VIVO sites, including Ospedale Della Misericordia Grosseto and Pisa CNR. VIVO received commendable feedback, recognizing its potential to revolutionize patient experience and EP lab efficiency."

Strengthening their foothold in Italy, Catheter Precision has strategically partnered with Precise S.r.l. "Our alliance with Precise S.r.l. is instrumental in solidifying our presence in the Italian medical landscape," Jenkins concluded.

In addition to VIVO, Catheter Precision will be present at other conferences also highlighting their newly introduced product, LockeT, a venous stasis closure device.

Future conferences that will highlight VIVO in the coming weeks are listed below.

• Irish Cardiac Society's 74th Annual Scietific Meeting, October 12-14, 2023:
  • Presentation: "Testing the Validity of VIVO Technology: A Deep Dive into Ventricular Onset Mapping" by Professor Szeplaki's team from Mater Private Hospital, Dublin.
• 18th Annual International Symposium on Ventricular Arrythmias, October 13-14, 2023
  • Location: Philadelphia, Pennsylvania
  • Spotlight: VIVO and LockeT products
• 7th Annual Society of Cardiac RN Meeting, October 19-20, 2023:
  • Location: Washington, DC
    • Presentation: "3D Mapping for Robotic Ventricular Ablations Using VIVO" by Dr. Benjamin D'Souza from Penn Presbyterian Medical Center, Philadelphia, PA.